6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
8m ago	Data at Heart Rhythm 2026 highlight key Boston Scientific therapies
1h ago	Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Trial on April 27, 2026
2h ago	Smart Money Quietly Accumulating as Lithium Demand Surges - Early Positioning in Elektros Signals Rare Ground-Floor Opportunity
6h ago	Neusoft Showcases Full-Stack & Global Innovations at Auto China 2026
6h ago	Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026

About

Boston Scientific Corp (NYSE:BSX) — investor relations, events, news, and company updates on 6ix.

Latest News

Data at Heart Rhythm 2026 highlight key Boston Scientific therapies

Boston Scientific announces results for first quarter 2026

Boston Scientific announces conference call discussing first quarter 2026 results

CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints

HI-PEITHO trial demonstrates Boston Scientific EKOS™ Endovascular System is superior to standard of care for treatment of acute pulmonary embolism

Financials

Revenue

$20.07 B

Market Cap

$93.36 B

P/E Ratio

32.38

EPS

1.94

Community Chat

Ask AI